Popular on EntSun
- Female Motorsports Sponsorship & Expansion; Acquisition Agreement of UAE-Based Sports Incubator by Online Lottery & Sports Game Provider: Lottery.com - 224
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator - 205
- WOA Entertainment Group Unveils Independent No.1's: Breakthrough Artists II —A Celebration of Indie Excellence - 205
- Edtech Startup Young Commanders Launches 'Visionaries Without Sight' Collection Celebrating Blind and Visually Impaired Historical Figures - 197
- Introducing Nene Wear: The Bold, Sporty Fashion Brand by Jeanne Myrick, Powered by KLM Enterprises - 184
- Let's Talk Series: At the Crossroads: Immigration Today - 145
- TEDxInglewood Returns to The Miracle Theater on August 9, 2025 — Celebrating Bold Ideas and Community Energy - 128
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement - 122
- Manhattan Boutique Real Estate Collaborates with InterContinental Hotels NYC in a Branding Partners Personalized Approach - 119
- Token-Operated Sake Service Opens at Tobu Nikko Station - 117
Similar on EntSun
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- $328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
- New AI Academy Helps Therapists Embrace Tech Without Losing Their Humanity
- Coker Completes Acquisition of Healthcare Cost Solutions, a Leading Expert in Technology-Enabled Compliance Services
- $750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
- NUFABRX awarded Therapeutic Compression agreement with Premier, Inc
- Baker Rights and Coercive Psychiatry: The Citizens Commission on Human Rights of Florida Hosts Monthly Mental Health Law and Human Rights Seminars
- Elevated Healing Treatment Centers: Redefining Mental Health Care with Compassionate, Evidence-Based, and Accessible Services
- Speranza Dental Implant Centers Opens Their First Location
Accel Research Sites now recruiting for new pediatric COVID-19 vaccine trial
EntSun News/10876583
LAKE MARY, Fla. - EntSun -- Accel Research Sites will serve as a location for a new clinical trial for a COVID-19 vaccine candidate—this time for children.
The company is now recruiting those younger than 18 to participate. Enrollment will start soon.
The studies will take place at Accel's DeLand, Fla., and Lakeland, Fla., locations. Dr. Bruce Rankin and Dr. James Andersen will serve as the primary investigators.
"We're so proud to have played a part in developing vaccines for COVID-19," said Lora Parahovnik, CEO of Accel Research Sites. "Now, we want to play a part in helping everyone get vaccinated. These pediatric trials will be essential in developing a safe vaccine for those under 18."
Parents or guardians who are interested in having their children participate in the study can visit covidorlando.com (http://www.covidorlando.com). An Accel staff member will reach out to further evaluate eligibility
More on EntSun News
Accel Research Sites seeks to enroll a wide variety of participants for the trials, including racial and ethnic minorities. The company is also still recruiting for other COVID-19-related trials.
Accel Research Sites provides novel treatment options in all major therapeutic areas. It has more than 30 locations, including a 62-bed Phase 1 unit in Florida and units in Georgia and Alabama.
For more information about Accel Research Sites, visit accelresearchsites.com.
About Accel Research Sites
Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.
The company is now recruiting those younger than 18 to participate. Enrollment will start soon.
The studies will take place at Accel's DeLand, Fla., and Lakeland, Fla., locations. Dr. Bruce Rankin and Dr. James Andersen will serve as the primary investigators.
"We're so proud to have played a part in developing vaccines for COVID-19," said Lora Parahovnik, CEO of Accel Research Sites. "Now, we want to play a part in helping everyone get vaccinated. These pediatric trials will be essential in developing a safe vaccine for those under 18."
Parents or guardians who are interested in having their children participate in the study can visit covidorlando.com (http://www.covidorlando.com). An Accel staff member will reach out to further evaluate eligibility
More on EntSun News
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
Accel Research Sites seeks to enroll a wide variety of participants for the trials, including racial and ethnic minorities. The company is also still recruiting for other COVID-19-related trials.
Accel Research Sites provides novel treatment options in all major therapeutic areas. It has more than 30 locations, including a 62-bed Phase 1 unit in Florida and units in Georgia and Alabama.
For more information about Accel Research Sites, visit accelresearchsites.com.
About Accel Research Sites
Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.
Source: Accel Research Sites
0 Comments
Latest on EntSun News
- Winners Announced for Asia Pacific Business Awards 2024-2025
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage
- Google AI Quietly Corrects the Record on Republic of Aquitaine's Legal Sovereignty
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence
- Make Innovation Matter: Support H.R.1's R&D Expensing Relief for American Small Businesses
- Agreement to Supply US-Based Defense Provider with Thin-Film Solar Tech for Orbital Application; Ascent Solar Technologies, Inc. (N A S D A Q: ASTI)
- Byrd Davis Alden & Henrichson Launches Independence Day Safe Ride Initiative with 500 Free Uber Credits
- Big Butler Fair Announces 2025 Music Lineup and Grandstand Events
- 2 Funny Native Comedy Night Comes To St Croix Casino Hertel
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- Black-Owned Media Continues To Take Center Stage:The Complete Network Officially Launches
- New PBS Travel TV Series Premieres as Host Michelle Valentine Celebrates 8-Year Wedding Anniversary
- Tucson, Arizona to be backdrop city for Vendetta Vette (c) Mini Movie Streaming late 2025
- Colorado Scenthound Locations Partner with Humane Colorado to Give Adopted Dogs a "Clean Start"
- Endoacustica Europe Unveils iPhone 13 Pro Max Spy Phone—Pure Hardware, Zero Software Changes
- Suzanne Harp named Managing Director in Texas, USA
- $10 Million Acquisition of GXR World Sports Assets Energizes Global Launch of Sports.com Super App by Online Lottery-Sports Game Provider: Lottery.com
- Shop American Made Goods: New Online Marketplace My American Goods Curates the Best of U.S. Made
- Investor Spotlight: Cycurion, Inc. (N A S D A Q: CYCU) Secures $69M in Contracts Amid Surging Demand for AI-Powered Cybersecurity Solutions